Evidence map›Paper›PMID 26137370›Full record

ArticleBiomedical optics express2015

Improved sparse reconstruction for fluorescence molecular tomography with L1/2 regularization.

Hongbo Guo, Jingjing Yu, Xiaowei He, Yuqing Hou, Fang Dong, Shuling Zhang

Abstract read
In one paragraph

Article in Biomedical optics express, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Recent methodology advances in fluorescence molecular tomography.Visual computing for industry, biomedicine, and art · 2018
    Review
  6. Article
  7. Review
  8. An LBiomedical engineering online · 2017
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hongbo GuoSchool of Information Sciences and Technology, Northwest University, Xi'an, 710069, China.
Jingjing YuSchool of Physics and Information Technology, Shaanxi Normal University, Xi'an, 710062, China.
Xiaowei HeSchool of Information Sciences and Technology, Northwest University, Xi'an, 710069, China.
Yuqing HouSchool of Information Sciences and Technology, Northwest University, Xi'an, 710069, China.
Fang DongSchool of Information Sciences and Technology, Northwest University, Xi'an, 710069, China.
Shuling ZhangSchool of Information Sciences and Technology, Northwest University, Xi'an, 710069, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorescence molecular tomography (FMT) is a promising imaging technique that allows in vivo visualization of molecular-level events associated with disease progression and treatment response. Accurate and efficient 3D reconstruction algorithms will facilitate the wide-use of FMT in preclinical research. Here, we utilize L1/2-norm regularization for improving FMT reconstruction. To efficiently solve the nonconvex L1/2-norm penalized problem, we transform it into a weighted L1-norm minimization problem and employ a homotopy-based iterative reweighting algorithm to recover small fluorescent targets. Both simulations on heterogeneous mouse model and in vivo experiments demonstrated that the proposed L1/2-norm method outperformed the comparative L1-norm reconstruction methods in terms of location accuracy, spatial resolution and quantitation of fluorescent yield. Furthermore, simulation analysis showed the robustness of the proposed method, under different levels of measurement noise and number of excitation sources.

Indexed as

(100.3190) Inverse problems(170.3010) Image reconstruction techniques(170.3880) Medical and biological imaging(170.6960) Tomography

Identifiers

PMID26137370
PMCPMC4467700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.